Quick takes on some emerging projects worth watching:

**Collaterize** gets a solid 7/10. Just launched with Anatoly's endorsement, which carries weight. Already seeing over $1M in daily buyback activity—that's serious commitment this early. Still finding its footing, but the backing speaks volumes.

**Tars Protocol** sits at 6/10. The fundamentals look promising—NVIDIA partnership isn't something you see every day, plus Solana Foundation is in their corner. The tech stack checks out. But here's the catch: down 92% from its peak. Classic case of strong infrastructure, brutal price action. Could be accumulation territory if you believe in the long game.

**PinLink** lands at 6.5/10. The rating suggests there's potential here, though specifics on execution and traction would help paint a clearer picture.

These scores reflect where projects stand right now—early-stage plays with varying risk profiles. Anatoly-backed projects tend to get attention fast, but remember that partnerships don't automatically translate to price pumps. Do your homework beyond the hype.